

          -  Participants already prescribed chloroquine, hydroxychloroquine, or azithromycin

          -  Allergy to hydroxychloroquine or azithromycin

          -  History of bone marrow transplant

          -  Known G6PD (Glucose-6-Phosphate Dehydrogenase Deficiency) deficiency

          -  Chronic hemodialysis, peritoneal dialysis, continuous renal replacement therapy or
             Glomerular Filtration Rate < 20ml/min/1.73m2

          -  Liver disease (e.g. Child Pugh score >= B or AST (Aspartate Transaminase)>2 times upper
             limit)

          -  Psoriasis

          -  Porphyria

          -  Known cardiac conduction delay (QTc > 500mSec) or taking any prescription medications
             known to prolong QT interval

          -  Concomitant use of digitalis, flecainide, amiodarone, procainamide, or propafenone

          -  Prisoner

          -  Weight < 35kg

          -  Inability to follow-up - no cell phone or no address or not Spanish or English
             speaking

          -  Receipt of any experimental treatment for SARS-CoV-2 (off-label, compassionate use, or
             trial related) within the 30 days prior to the time of the screening evaluation

          -  No symptoms attributable to COVID-19

          -  Pregnant or nursing
      